ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 364170 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 364170; 2) Community: the network communities that were significantly associated with the response to NSC 364170; 3) Molecule: the relationships between components within communities and NSC 364170; 4) MDR: the compounds that were significantly associated with the NSC 364170.

NSC Compound Enrichment Correlation
NSC 751342 12H-Benzo[g]pyrido[2,1-b]quinazoline-4-carboxamide, N-[2(dimethylamino)ethyl]-12-oxo 0.0385613993886001 0.10939039
NSC 756278 GW612286X 0.0385613993886001 -0.22940909
NSC 759878 Irinotecan hydrochloride (USAN) 0.0385613993886001 0.28392285
NSC 88916 10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one 0.0385613993886001 0.25228796
NSC 10848 Null 0.0414190425892865 0.043813779
NSC 130862 Null 0.0414190425892865 0.33464382
NSC 134754 Null 0.0414190425892865 0.2782961
NSC 154829 7H-Pyrrolo[2,3-d]pyrimidine-5-carboxamidoxime, 4-(hydroxyamino)-7-.beta.-D-ribofuranosyl-, monohydrochloride 0.0414190425892865 0.089360556
NSC 282880 Ethanaminium, 2-[[hydroxy(octadecyloxy)phosphinyl]oxy]-N,N,N-trimethyl-, inner salt (9CI) 0.0414190425892865 0.043311599
NSC 3088 Chlorambucil 0.0414190425892865 0.33869024
Total:73  Current:52    [First] [Prev] [Next] [Last]